Skip to main content

Genetik der Alzheimer Demenz

  • Conference paper
Alzheimer Demenz

Zusammenfassung

Genetisch epidemiologische Studien dienen der Abschätzung der Bedeutung von genetischen Faktoren für die Entwicklung einer Krankheit, einer Störung oder eines anderen Merkmals. Klassische Studiendesigns ohne den Einsatz genetischer Marker sind Zwillingsstudien, Familienstudien und Adoptionsstudien. Diese Studien erlauben jedoch nur die Abschätzung einer vorhandenen Erblichkeit, nicht aber die Identifizierung von krankheitsrelevanten Genen. Assoziations- und Kopplungsuntersuchungen nutzen hingegen genetische Marker, um den Zusammenhang zwischen Auftreten eines Markers und einer Erkrankung in Populationen oder in Familien bzw. Stammbäumen festzustellen und so krankheitsrelevante Gene zu identifizieren. Im folgenden werden die Ergebnisse aus den publizierten Zwillingsstudien, Familienstudien, Kopplungs- und Assoziationsuntersuchungen zur Alzheimer Demenz (AD) dargestellt und im Hinblick auf ihre klinische Relevanz diskutiert. Adoptionsstudien zur AD wurden bisher nicht publiziert.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Altstiel LD, Lawlor B, Mohs R, Schmeidler J, Dalton A, Mehta P, Davis K (1995) Elevated Alpha-1-Antichymotrypsin Serum Levels in a Subset of Nondemented First-Degree Relatives of Alzheimer’s Disease Patients. Dementia 6: 17–20

    PubMed  CAS  Google Scholar 

  • Alzheimer’s Disease Collaborative Group (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD farnilies. Nat Genet 11: 219–22

    Google Scholar 

  • Alzheimer’s Disease Collaborative Group (1993) Apolipoprotein E genotype and Alzheimer’s disease. Lancet 342: 737–738

    Google Scholar 

  • Benjamin R, Leake A, Mcarthur FK et al. (1996) Apolipoprotein E Genotype and Alzheimer’s Disease in an Elderly Norwegian Cohort, Neurodegeneration 5: 43–47

    PubMed  CAS  Google Scholar 

  • Bergem ALM, Engedal K, Kringlen E (1997) The Role of Heredity in Late-Onset Alzheimer Disease and Vascular Dementia. Arch Gen Psychiatry 54: 264–270

    PubMed  CAS  Google Scholar 

  • Besancon R, Lorenzi A, Cruts M et al. (1997) Missense Mutation in Exon 11 (Codon 378) of the Presenilin-1 Gene in a French Family With Early-Onset Alzheimer’s Disease and Transmission Study by Mismatch Enhanced Allele Specific Amplifkation. Human Mutation, Mutation in Brief #141 Online

    Google Scholar 

  • Blacker D, Haines JL, Rodes L et al. (1997) ApoE-4 and age at onset of Alzheimer’s disease: The NIMH Genetics Initiative. Neurology 48: 139–147

    PubMed  CAS  Google Scholar 

  • Blacker D, Wilcox MA, Laird NM et al. (1998) Alpha-2 macroglobukin is genetically associated with Alzheimer disease. Nature Genet 19: 357–360

    PubMed  CAS  Google Scholar 

  • Boteva K, Vitek M, Mitsuda H, de Silva H, Xu PT, Small G, Gilbert JR (1996) Mutation analysis of presenillin 1 gene in Alzheimer’s disease. Lancet 347: 130–131

    PubMed  CAS  Google Scholar 

  • Breitner JCS, Folstein MF(1984) Familial Alzheimer Dementia: a prevalent disorder with specific clinical features. Psychological Medicine 14: 63–80

    PubMed  CAS  Google Scholar 

  • Breitner JCS, Murphy EH, Silverman JM, Mohs RC, Davis KL (1988) Age-dependent Expression of Familial Risk in Alzheimer’s Disease. American Journal of Epidemiology 128: 536–548

    PubMed  CAS  Google Scholar 

  • Breitner JCS, Silverman JM, Mohs RC, Davis KL (1988) Familial aggregation in Alzheimer’s disease: Comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations. Neurology 38: 207–212

    PubMed  CAS  Google Scholar 

  • Breitner JCS, Murphy EA (1992) Twin Studies of Alzheimer Disease : II. Some Predictions Under a Genetic Model. American Journal of Medical Genetics 44: 628–634

    PubMed  CAS  Google Scholar 

  • Breitner JCS, Welsh KA, Gau BA et al. (1995) Alzheimer’s Disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. Arch Neurol 52: 763–771

    PubMed  CAS  Google Scholar 

  • Brindle N, Song Y, Rogaeva E et al. (1998) Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease. Hum Mol Genet 7: 933–935

    PubMed  CAS  Google Scholar 

  • Brookes AJ, Clair DS(1994) Synuclein proteins and Alzheimer’s disease. TINS 17: 404–405

    PubMed  CAS  Google Scholar 

  • Bullido MJ, Artiga MJ, Recuero M et al. (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer’s dementia. Nature Genet 18: 69–71

    PubMed  CAS  Google Scholar 

  • Cai X, Stanton J, Fallin D et al. (1997) No Association Between the Intronic Presenelin-1 Polymophism and Alzheimer’s Disease in Clinic and Population-Based Samples. Amercian Journal of Medical Genetics 74: 202–203

    CAS  Google Scholar 

  • Campion D, Flaman JM, Brice A et al. (1995) Mutations of the presenilin I gene in families with early-onset Alzheimer’s disease. Hum Mol Genet 4: 2373–2377

    PubMed  CAS  Google Scholar 

  • Campion D, Martin C, Heilig R et al. (1995) The NACP/Synuclein Gene: Chromosomal Assignment and Screening for Alterations in Alzheimer Disease. Genomics 26: 254–257

    PubMed  CAS  Google Scholar 

  • Chandra V, Philipose V, Bell PA, Lazaroff A, Schoenberg BS (1987) Case-control study of late onset “probable Alzheimer’s disease”. Neurology 37: 1295–1300

    PubMed  CAS  Google Scholar 

  • Chandrasekaran K, Hatanpää K, Rapoport SI, Brady DR(1997) Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease. Molecular Brain Research 44: 99–104

    PubMed  CAS  Google Scholar 

  • Chartier-Harlin MC, Crawford F, Houlden H et al. (1991) Early-onset Alzheimer’s disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353: 844–846

    PubMed  CAS  Google Scholar 

  • Chung H, Roberts CT, Greenberg S, Rebeck W, Christie R, Wallace R, Jacob HJ, Hyman BT (1996) Lack of Association of Trinucleotide Repeat Polymorphisms in the Very-Low-Density Lipoprotein Receptor Gene with Alzheimer’s Disease. Annais of Neurology 39: 800–803

    CAS  Google Scholar 

  • Clark RF, Goate AM(1993) Molecular genetics of Alzheimer’s disease. Arch Neurol 50: 1164–1172

    PubMed  CAS  Google Scholar 

  • Combarros O, Leno C, Oterino A et al. (1998) Gender effect on apolipoprotein E e4 allele-associated risk for sporadic Alzheimer’s disease. Acta Neurol Scand 97: 68–71

    PubMed  CAS  Google Scholar 

  • Corder EH, Saunders AM, Risch NJ et al. (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics 7: 180–184

    PubMed  CAS  Google Scholar 

  • Corder EH, Saunders AM, Strittmatter WJ et al. (1993) Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer’s Disease in Late Onset Families. Science 261: 921–923

    PubMed  CAS  Google Scholar 

  • Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, McKee AC, Beal MF, Graham BH, Wallace DC (1994) Marked Changes in Mitochondrial DANN Deletion Levels in Alzheimer Brains. Genomics 23: 471–476

    PubMed  CAS  Google Scholar 

  • Crawford F, Fallin D, Suo Z, Abdullah L, Gold M, Gauntlett A, Duara R, Mullan M (1998) The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinicand community-based populations. Neurosci Lett 249:115–118

    PubMed  CAS  Google Scholar 

  • Cruts M, Backhovens H, Wang SY et al. (1995) Molecular genetic analysis of familial early-onset Alzheimer’s disease linked to chromosome 14q24.3. Hum Mol Genet 4: 2363–2371

    PubMed  CAS  Google Scholar 

  • Cruts M, van Duijn CM, Backhovens H et al. (1998) Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer Disease Hum Mol Genet (in press)

    Google Scholar 

  • Császár A, Kálmán J, Szalai C, Janka Z, Romics L(1997) Association of the apolipoprotein A-IV codon 360 mutation in patients with Alzheimer’s disease. Neurosci Lett 230: 151–154

    PubMed  Google Scholar 

  • Delasnerie-Laupretre N, Calot M, Ohayon E, Foucault C, Cambon-de-Mouzon A, Clanet M, Cathala F (1983) Alzheimer Familial: Etüde des Marqueurs HLA. Biomedicine & Pharmacotherapy, 37: 186–188

    CAS  Google Scholar 

  • Didierjean O, Martinez M, Campion D et al. (1997) No effect of the al-antichymotrypsin A allele in Alzheimers disease. J Neurol Neurosurg Psychiatry 63: 103–105

    PubMed  CAS  Google Scholar 

  • Duara R, Barker WW, Loper-Alberola R, Loewenstein DA, Grau LB, Gilchrist D, Sevush S, George-Hyslop PHS (1996) Alzheimer’s disease: Interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 46: 1575–1579

    PubMed  CAS  Google Scholar 

  • Eckman CB, Mehta ND, Crook R et al. (1997) A new pathogenic mutation in the APP gene (17I6V) increases the relative proportion of A beta 42 (43). Hum Mol Genet 6: 2087–2089

    PubMed  CAS  Google Scholar 

  • Evans DA, Beckett LA, Field TS, Feng L, Albert MS, Bennett DA, Tycko B, Mayeux R (1997) Apolipoprotein E e4 and Incidence of Alzheimer Disease in a Community Population of Older Persons. JAMA 277: 822–824

    PubMed  CAS  Google Scholar 

  • Fallin D, Gauntlett AC, Scibelli P, Cai X, Duara R, Gold M, Crawford F, Mullan M (1997) No Association Between the Very Low Density Lipoprotein Receptor Gene and Late-Onset Alzbeimer’s Disease Nor Interaction With the Apolipoprotein E Gene in Population-Based and Clinic Samples. Genetic Epidemiology 14: 299–305

    PubMed  CAS  Google Scholar 

  • Farlow MR Lahiri DK, Poirier J, Davignon J, Schneider L, Hui SL (1998) Treatment outcorne of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer’s disease. Neurology 50: 669–677

    PubMed  CAS  Google Scholar 

  • Farrer LA, Cupples LA, van Duijn CM et al. (1995) Apolipoprotein E Genotype in Patients with Alzheimer’s Disease: Implications for the Risk of Dementia Among Relatives. Ann Neurol 38: 797–808

    PubMed  CAS  Google Scholar 

  • Farrer LA, Meyers RH, Cupples IA et al. (1990) Transmission and Age-at-onset Patterns in Familial Alzheimers Disease: Evidence of Heterogeneity. Neurology 40: 395–403

    PubMed  CAS  Google Scholar 

  • Farrer LA, O’Sullivan DM, Cupples LA, Growden JH, Myers RH (1989) Assessment of genetic risk for Alzheimer’s disease among first-degree relatives. Ann Neurol 25: 485–493

    PubMed  CAS  Google Scholar 

  • Fitch N, Becker R, Heller A (1988) The inheritance of Alzheimer’s disease: a new interpretation. Ann Neurol 23: 14–19

    PubMed  CAS  Google Scholar 

  • Forsell C, Froelich S, Axelman K et al. (1997) A novel pathogenic mutation (Leu262Phe) found in the presenilin 1 gene in early-onset Alzheimer’s disease. Neurosci Lett 234: 3–6

    PubMed  CAS  Google Scholar 

  • Frisoni GB, Manfredi M, Geroldi C, Binetti G, Zanetti 0, Bianchetti A, Trabucchi M (1998) The prevalence of apoE-e4 in Alzheimer’s disease is age dependent. J Neurol Neurosurg Psychiatry 65: 103–106

    PubMed  CAS  Google Scholar 

  • Frohman EM, Frohman TC, Gupta S, de Fougerolles A, van den Noort S (1991) Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer’s disease. J of the Neurological Sciences 106: 105–111

    CAS  Google Scholar 

  • Gabriel SM, Marin DB, Aisen PS, Lantz M, Altstiel LD, Davis KL, Mohs RC (1998) Association of Elevated al-Antichymotrypsin With Cognitive Impairment in a Prospective Study of the Very Old. Am J Psychiatry 155: 698–700

    PubMed  CAS  Google Scholar 

  • Gatz M, Pedersen NL, Berg S et al. (1997) Heritability for Alzheimer’s Disease: The Study of Dementia in Swedish Twins. Journal of Gerontology: Medical Sciences 52A: 117–125

    Google Scholar 

  • Goate AM, Chartier-Harlin MC, Mullan M et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349: 704–706

    PubMed  CAS  Google Scholar 

  • Gomez-Isla T, Wasco W, Pettingeil WP et al. (1997) A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes. Ann Neurol 41: 809–813

    PubMed  CAS  Google Scholar 

  • Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT (1996) Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer’s disease. Neurology 47: 444–448

    PubMed  CAS  Google Scholar 

  • Haan J, van Broeckhoven C, van Duijn CM et al. (1994) The Apolipoprotein E e4 Allele Does Not Influence the Clinical Expression of the Amyloid Precursor Protein Gene Codon 693 or 692 Mutations. Ann Neurol 36: 434–437

    PubMed  CAS  Google Scholar 

  • Haines JL, Pritchard ML, Saunders AM et al. (1996) No Genetic Effect of al- Antichymotrypsin in Alzheimer Disease. Genomics 33: 53–56

    PubMed  CAS  Google Scholar 

  • Harr SD, Uint L, Hollister R, Hyman BT, Mendez AJ (1996) Brain Expression of Apolipoproteins E, J, und A-I in Alzheimer’s Disease. Journal of Neurochemistry 2429-2435

    Google Scholar 

  • Harrison P (1993) Alzheimer’s disease and chromosome 14. Different gene, same process?Br J Psychiatry 163: 2–5

    PubMed  CAS  Google Scholar 

  • Haupt M, Kurz A, Pollmann S, Romero B (1992) Alzheimer’s disease: identical phenotype of familial and non-famiüal cases. J Neurol 239: 248–250

    PubMed  CAS  Google Scholar 

  • Henderson AS, Jorm AF, Korten AE, Creasey H, McCusker E, Broe GA, Longley W, Anthony JC (1992) Environmental risk factors for Alzheimer’s disease: their relationship to age of onset and to familial or sporadic types. Psychological Medicine 22: 429–436

    PubMed  CAS  Google Scholar 

  • Hendrie HC, Hall KS, Hui S et al. (1995) Apolipoprotein E Genotypes and Alzheimer’s Disease in a Community Study of Elderly African Americans. Ann Neurol 37: 118–120

    PubMed  CAS  Google Scholar 

  • Hendriks L, van Duijn CM, Cras P et al. (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nature Genet 1: 218–221

    PubMed  CAS  Google Scholar 

  • Heston LL, Mastri AR, Anderson VE, White J (1981) Dementia of the Alzheimer type. Clinical genetics, natural history and associated conditions. Arch Gen Psychiatry 38: 1085–1090

    PubMed  CAS  Google Scholar 

  • Heun R, Maier W (1995) Risks of Alzheimer’s disease in First-Degree Relatives. Archives of General Psychiatry 52:317–318

    PubMed  CAS  Google Scholar 

  • Heyman A, Wilkinson WE, Hurwitz BJ, Schmechel D, Sigmon AH, Weinberg T, Helms MJ, Swift M (1983) Alzheimer’s Disease: Genetic Aspects and Associated Clinical Disorders. Ann Neurol 14: 507–515

    PubMed  CAS  Google Scholar 

  • Higuchi SM, Muramatsu T, Matsushita S, Arai H, Sasaki H (1996) Presenelin-1 polymorphism. National Institute on Alcoholism

    Google Scholar 

  • Hiltunen M, Mannermaa A, Helisalmi S, Koivisto A, Lehtovirta M, Ryynanen M, Riekkinen PS, Soininen H (1998) Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer’s disease patients. Neurosci Lett 250: 69–71

    PubMed  CAS  Google Scholar 

  • Hofman A, Schulte W, Tanja TA et al. (1989) History of Dementia and Parkinson’s Disease in lst degree Relatives of Patients with Alzheimer’s disease. Neurology 39: 1589–1592

    PubMed  CAS  Google Scholar 

  • Hollister RD, Xia M, Mcnamara MJ, Hyman BT (1997) Neuronal Expression of Class II Major Histocompatibility Complex (HLA-DR) in 2 Cases of Pick Disease. Arch Neurol 54: 243–248

    PubMed  CAS  Google Scholar 

  • Holmes C, Arranz MJ, Powell JF, Collier DA, Lovestone S (1998) 5-HT 2A and 5-HT 2 C receptor polymorphisms and psychopathology in late onset Alzheimer’s disease. Human Molecular Genetics 7: 1507–1509

    PubMed  CAS  Google Scholar 

  • Horn J, Turner MB, Risser R, Bonte FJ, Tintner R (1994) Cognitive Deficits in Asymptomatic First-Degree Relatives of Alzheimer’s Disease Patients. Journal of Clinical and Experimental Neuropsychology 16: 568–576

    Google Scholar 

  • Houlden H, Crook R, Hardy J, Roques P, Colünge J, Rossor M(1994) Confirmation that familial clustering and age of onset in late onset Alzheimer’s disease are determined at the apolipoprotein E locus. Elsevier Neuroscience Letters 174: 222–224

    CAS  Google Scholar 

  • Houlston RS, Snowden C, Green F, Alberti KGMM, Humphries SE (1989) Apolipoprotein (apo) E genotypes by Polymerase chain reaction and allele-specific oligonucleotide probes: no detectable linkage disequilibrium between apoE and apoCll. Hum Genet 83: 998–1014

    Google Scholar 

  • Huff FJ, Auerbach J, Chakravarti A, Boller F (1988) Risk of dementia in relatives of patients with Alzheimer’s disease. Neurology 38: 786–790

    PubMed  CAS  Google Scholar 

  • Hutchin T, Cortopassi G (1995) A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sei 92: 6892–6895

    CAS  Google Scholar 

  • Hutton M, Busfield F, Wragg M et al. (1996) Complete analysis of the presenilin 1 gene in early onset Alzheimer’s disease. Neuroreport 7: 801–805

    PubMed  CAS  Google Scholar 

  • Jarvik LF, Ruth V, Matsuyama SS (1980) Organic Brain Syndrome and Ageing: A Six-Year Follow Up Of Surviving Twins. Arch Gen Psychiatry 37: 280–286

    PubMed  CAS  Google Scholar 

  • Jarvik GP, Larson EB, Goddard K, Kukull WA, Schellenberg GD, Wijsman EM (1996) Influence of Apolipoprotein E Genotype on the Transmission of Alzheimer Disease in a Community-Based Sample. Am J Hum Genet 58: 191–200

    PubMed  CAS  Google Scholar 

  • Jefferies WA, Food MR, Gabathuler R, Rothenberger S, Yamada T, Yasuhara O, McGeer PL (1996) Reactive microglia speeifieally associated with amyloid plaques in Alzheimer’s disease brain tissue express melanotransferrin. Brain Research 712: 122–126

    PubMed  CAS  Google Scholar 

  • Jorgensen P, Bus C, Pallisgaard N, Bryder M, Jorgensen AL (1996) Familial Alzheimer’s disease co-segregates with a Metl46Ile substitution in presenilin-1. Clin Genet 50: 281–286

    PubMed  CAS  Google Scholar 

  • Kamboh MI (1995) Apolipoprotein E Polymorphism and Susceptibility to Alzheimer’s Disease. Human Biology 67: 195–215

    PubMed  CAS  Google Scholar 

  • Kamboh MI, Sanghera DK, Ferrell RE, Dekosky ST(1995) APOE*4-associated Alzheimer’s disease risk is modified by (al-antichymotrypsin polymorphism. Nature Genetics 10: 486–488

    PubMed  CAS  Google Scholar 

  • Kamino K, Sato S, Sakaki Y et al. (1996) Three different mutations of presenilin 1 gene in early-onset Alzheimer’s disease families. Neurosci Lett 208: 195–198

    PubMed  CAS  Google Scholar 

  • Karlinsky H, MacDonald AM, Berg JM (1992) Primary degenerative dementia of the Alzheimer type in twins: Initial findings from the Maudsley Hospital Twin Register. International Journal of Geriatrie Psychiatry 7: 603–610

    Google Scholar 

  • Kehoe P, Williams J, Lovestone S, Wilcock G, Owen MJ (1996) Presenelin-1 polymorphism and Alzheimer’s disease. Lancet 1185-1186

    Google Scholar 

  • Kennard ML, Feldman H, Yamada T, Jefferies WA (1996) Serum levels of the iron binding protein p97 are elevated in Alzheimer’s disease. Nature Medicine 2: 1230–1235

    PubMed  CAS  Google Scholar 

  • Korten AE, Jorm AF, Henderson AS, Broe GA, Creasey H, Mccusker E(1993) Assessing the risk of Alzheimer’s disease in first-degree relatives of Alzheimer’s disease cases. Psychological Medicine 23: 915–923

    PubMed  CAS  Google Scholar 

  • Kösel S, Egensperger R, Mehraein P, Graeber MB (1994) No Association of Mutations at Nucleotide 5460 of Mitochondrial NADH Dehydrogenase with Alzheimer’s disease. Biochemical and Biophysical Research Communications 203: 745–749

    PubMed  Google Scholar 

  • Kurz A, Egensperger R, Haupt M, Lautenschlager N, Romero B, Graeber MB, Müller U(1996) Apolipoprotein E e4 allele cognitive decline, and deterioration of everyday Performance in Alzheimer’s disease. Neurology 47: 440–443

    PubMed  CAS  Google Scholar 

  • Kwok JB, Taddei K, Hallupp M et al. (1997) Two novel (M233T and R278T) presenilin-1 mutations in earlyonset Alzheimer’s disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport 8: 1537–1542

    PubMed  CAS  Google Scholar 

  • Lamb H, Christie J, Singleton AB et al. (1998) Apolipoprotein E and alpha-1 antiehymotrypsin polymorphism genotyping in Alzhneimer’s disease and in dementia with Lewy bodies. Neurology 50: 388–391

    PubMed  CAS  Google Scholar 

  • Lambert JC, Wavrant-De Vrieze F, Amouyel P, Chartier-Harlin MC (1998) Association at LRP gene locus with sporadic late-onset Alzheimer’s disease. Lancet 351: 1787–1788

    PubMed  CAS  Google Scholar 

  • Lannfelt L, Citron M, Tanzi R et al. (1996) The Presenilin 1 and 2 mutations linked to familial Alzheimer’s disease increase the extracellular concentration of amyloid ß protein (Aß) ending at Aß 42 (43). Neurobiol Aging 17: S38 (Abstract)

    Google Scholar 

  • Lautenschläger NT, Cupples LA, Rao VS et al. (1996) Risk of dementia among relatives of Alzheimer’s disease patients in the MIRAGE study: What is in störe for the oldest old? Neurology 46: 641–650

    PubMed  Google Scholar 

  • Lehmann DJ, Johnston C, Smith AD (?) Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer’s disease. Human Molecular Genetics 6: 1933-1936

    Google Scholar 

  • Lendon CL, Talbot CJ, Craddock NJ, Han SW, Wragg M, Morris JC, Goate AM (1997) Genetic association studies between dementia of the Alzheimer’s type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett 222: 187–190

    PubMed  Google Scholar 

  • Levy E, Carman MD, Femandez-Madrid IJ et al. (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248: 1124–1126

    CAS  Google Scholar 

  • Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KAB, Weber JL, Bird TD, Schellenberg GD (1995a) A Familial Alzheimer’s Disease Locus on Chromosome 1. Science 269: 970–973

    PubMed  CAS  Google Scholar 

  • Levy-Lahad E, Wasco W, Poorkaj P et al. (1995b) Candidate Gene for the Chromosome 1 Familial Alzheimer’s Disease Locus. Science 269: 973–977

    PubMed  CAS  Google Scholar 

  • Li G, Silverman JM, Altstiel LD et al. (1996) Apolipoprotein E-e4 Allele and Familial Risk in Alzheimer’s Disease. Genetic Epidemiology 13: 285–298

    PubMed  CAS  Google Scholar 

  • Li G, Silverman JM, Smith CJ, Zaccario ML, Schmeidler J, Mohs RC, Davis KL(1995) Age at Onset and Familial Risk in Alzheimer’s Disease. Am J Psychiatry 152: 424–430

    PubMed  CAS  Google Scholar 

  • Lopez OL, Kamboh MI, Becker JT, Kaufer DI, Dekosky ST (1997) The apolipoprotein E 4 allele is not associated with Psychiatric symptoms or extrapyramidal signs in probable Alzheimer’s disease. Neurology 49: 794–797

    PubMed  CAS  Google Scholar 

  • Lukacs CM, Christiansen DW (1996) Is the Binding of ß-Amyloid Protein to Antichymotrypsin in Alzheimer Plaques Mediated by a ß-Strand Insertion?Proteins 25: 420–424

    PubMed  CAS  Google Scholar 

  • Ma J, Yee A, Brewer HB jr, Das S, Potter H (1994) Amyloid-associated proteins al-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer ß-protein into filaments. Nature 372: 92–94

    PubMed  CAS  Google Scholar 

  • Macgowan SH, Wilcock GK, Scott M (1998) Effect of Gender and Apolipoprotein E genotype on response to acetylcholinesterase therapy in Alzheimer’s disease. International Journal of Geriatrie Psychiatry 13: 612–630

    Google Scholar 

  • Martin RL, Gerteis G, Gabrielli WF jr (1988) A Family-Genetic Study of Dementia of Alzheimer Type. Arch Gen Psychiatry 45: 894–900

    PubMed  CAS  Google Scholar 

  • Martinez M, Campion D, Brice A et al. (1998) Apolipoprotein E e4 Allele and Familial Aggregation of Alzheimer Disease. Arch Neurol 55: 810–816

    PubMed  CAS  Google Scholar 

  • Mattson MP (1997) Mother’s legaey: mitochondrial DANN mutations and Alzheimer’s disease. TINS 20: 373–375

    PubMed  CAS  Google Scholar 

  • Mayeux R, Ottman R, Maestr G et al. (1995) Synergistic effects of traumatic head injury and apolipoprotein-e4 in patients with Alzheimer’s disease. Neurology 45: 555–557

    PubMed  CAS  Google Scholar 

  • Mayeux R, Sano M, Chen J, Tatemichi T, Stern Y (1991) Risk of Dementia in First-Degree Relatives of Patients With Alzheimer’s Disease and Related Disorders. Archives of Neurology 48: 269–273

    PubMed  CAS  Google Scholar 

  • Mayeux R, Ottman R, Tang MX, Noboa-Bauza L, Marder K, Gurland B, Stern Y (1993) Genetic Susceptibility and Head Injury as Risk Factors for Alzheimer’s Disease Among Community-dwelling Elderly Persons and their First-degree Relatives. Ann Neurol 33: 494–501

    PubMed  CAS  Google Scholar 

  • Mcclearn GE, Johansson B, Berg S, Pedersen NL, Ahern F, Petrill SA, Plomin R (1997) Substantial Genetic Influence on Cognitive Abilities in Twins 80 or More Years Old. Science 276: 1560–1563

    PubMed  CAS  Google Scholar 

  • Mcgeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 38: 1285–1291

    PubMed  CAS  Google Scholar 

  • Meyer MR, Tschanz JT, Norton MC, Welsh-Bohmer KA, Steffens DC, Wyse BW, Breitner JCS (1998) APOE genotype predicts when-not wheter-one is predisposed to develop Alzheimer disease. Nature genetics 19: 321–322

    PubMed  CAS  Google Scholar 

  • Mohs RC, Breitner JCS, Silverman JM, Davis KL (1987) Alzheimer’s Disease. Arch Gen Psychiatry 44: 405–408

    PubMed  CAS  Google Scholar 

  • Mohs RC, Breitner JCS, Silverman JM, Davis KL (1988) Morbid Risk in First-Degree Relatives of Persons With Alzheimer’s Disease Archives of General Psychiatry 45: 97–98

    Google Scholar 

  • Montoya SE, Astson CE, DeKosky ST, Kamboh MI, Lazo JS, Ferrell RE (1998) Bleomycin hydrolase is associated with risk of sporadic Alzheimer’s disease. Nature Genetics 18: 211–212

    PubMed  CAS  Google Scholar 

  • Mui S, Briggs M, Chung H, Wallace RB, Gomez-Isla T, Rebeck GW, Hyman BT (1996) A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer’s disease and strongly with the e4 allele. Neurology 47: 196–201

    PubMed  CAS  Google Scholar 

  • Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L (1992) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1: 345–347

    PubMed  CAS  Google Scholar 

  • Müller U, Bödeker RH, Gerundt I, Kurz A(1996) Lack of association between cxl-antichymotrypsin polymorphism, Alzheimer’s disease, and allele e4 of apolipoprotein E. Neurology 47: 1575–1577

    PubMed  Google Scholar 

  • Murphy GM, Sullivan EV, Gallagher-Thompson D et al. (1997) No association between the alpha 1-antichymotrypsin A allele and Alzheimer’s disease. Neurology 19: 1313–1316

    Google Scholar 

  • Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254: 97–99

    PubMed  CAS  Google Scholar 

  • Nacmias B, Latorraca S, Piersanti P, Forleo P, Piacentini S, Bracco L, Amaducci L, Sorbi S (1995) ApoE genotype and familial Alzheimer’s disease: a possible influence on age of onset in APP717 Val ® Ile mutated families. Elsevier Neuroscience Letters 183: 1–3

    CAS  Google Scholar 

  • Nacmias B, Tedde A, Latorraca S (1996) Apolipoprotein E and al-Antichymotrypsin Polymorphism in Alzheimer’s Disease. Ann Neurol 40: 678–680

    PubMed  CAS  Google Scholar 

  • Namekata K, Imagawa M, Terashi A, Ohta S, Oyama F, Ihara Y (1997) Association of transferrin C2 allele with late-onset Alzheimer’s disease. Hum Genet 101: 126–129

    PubMed  CAS  Google Scholar 

  • Nee LE, Eldridge R, Sunderland T et al. (1987) Dementia of the Alzheimer type: Clinical and family study of 22 twin pairs. Neurology 37: 359–363

    PubMed  CAS  Google Scholar 

  • Neri C, Mayeux R, O’Neill GJ (1984) HLA-linked complement markers in Alzheimer’s and Parkinson’s disease: C4 variant (C4B2) a possible marker for senile dementia of the Alzheimer type. Neurology 34: 310–314

    Google Scholar 

  • Okuizumi K, Onodera O, Namba Y et al. (1995) Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer’s disease. Nature Genetics 11: 207–209

    PubMed  CAS  Google Scholar 

  • Oliveira JR, Filho JL, Shimokomaki CM, Okuma M, Passos-Bueno MR, Zatz M, Brito-Marques PR (1997) The Use of Apolipoprotein E Genotype for Preclinical Detection of Risk’s Group for Alzheimer’s Disease. American Journal of Medical Genetics 74: 216–217

    PubMed  CAS  Google Scholar 

  • Osuntokum BO, Sahota A, Ogunniyi AO et al. (1995) Lack of an Association Between Apolipoprotein E e4 and Alzheimer’s Disease in Elderly Nigerians. Ann Neurol 38: 463–465

    Google Scholar 

  • Payami H, Kaye J, Becker W, Norman D, Wetzsteon P (1991) HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic Alzheimer’s disease in men. Neurology 41: 1544–1548

    PubMed  CAS  Google Scholar 

  • Payami H, Schellenberg GD, Zareparsi S et al. (1997) Evidence for association of HLA-A2 allele with onset age of Alzheimer’s disease. Neurology 49: 512–518

    PubMed  CAS  Google Scholar 

  • Payami H, Zareparsi S, Montee KR et al. (1996) Gender Difference in Apolipoprotein E-Associated Risk for Familial Alzheimer Disease: A Possible Clue to the Higher Incidence of Alzheimer Disease in Women. Am J Hum Genet 58: 803–811

    PubMed  CAS  Google Scholar 

  • Pedersen NL, Gatz M, Winblad B, Pearson CG, Berg S (1989) Dementias in Swedish twins. Prog Clin Biol Res 317: 217–22

    PubMed  CAS  Google Scholar 

  • Perez-Tur J, Froelich S, Prihar G et al. (1995) A mutation in Alzheimer’s disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7: 297–301

    PubMed  CAS  Google Scholar 

  • Perez-Tur J, Croxton R, Wright K et al. (1996) A further presenilin 1 mutation in the exon 8 Cluster in familial Alzheimer’s disease. Neurodegeneration 5: 207–212

    PubMed  CAS  Google Scholar 

  • Pericak-Vance MA, Bass MP, Yarnaoka LH (1997) Complete Genomic Screen in Late-Onset Familial Alzheimer Disease. JAMA 278: 1237–1241

    PubMed  CAS  Google Scholar 

  • Poorkaj P, Sharma V, Anderson L et al. (1998) Missense mutations in the chromosome 14 familial Alzheimer’s disease presenilin 1 gene. Human Mutation 11: 216–221

    PubMed  CAS  Google Scholar 

  • Pritchard ML, Saunders AM, Gaskell PC et al. (1996) No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians. Neurosci Lett 209: 105–108

    PubMed  CAS  Google Scholar 

  • Räihä I, Kaprio J, Koskenvuo M, Rajala T, Sourander L (1996) Alzheimer’s disease in Finnish twins. Lancet 347: 573–578

    PubMed  Google Scholar 

  • Rao VS, Cupples A, van Duijn CM et al. (1996) Evidence for Major Gene Inheritance of Alzheimer Disease in Families of Patients With and Without Apolipoprotein E e4. Am J Hum Genet 59: 664–675

    PubMed  CAS  Google Scholar 

  • Renvoize EB (1984) An HLA and family study of Alzheimer’s disease. Psychological Medicine 14: 515–520

    PubMed  CAS  Google Scholar 

  • Reznik-Wolf H, Treves TA, Davidson M et al. (1996) A novel mutation of presenilin 1 in familial Alzheimer’s disease in Israel detected by denaturing gradient gel electrophoresis. Hum Genet 98: 700–702

    PubMed  CAS  Google Scholar 

  • Rogaev EI, Sherrington R, Rogaeva EA et al. (1995) Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature 376: 775–778

    PubMed  CAS  Google Scholar 

  • Rossor MN, Fox NC, Beck J, Campbell TC, Collinge J (1996) Incomplete penetrance of familial Alzheimer’s disease in a pedigree with a novel presenilin-1 gene mutation. Lancet 347: 1560

    PubMed  CAS  Google Scholar 

  • Russ C, Powell J, Lovestone S, Holmes C (1998) K variant of butyrycholinesterase and late-onset Alzheimer’s disease. Lancet 351: 881

    PubMed  CAS  Google Scholar 

  • Sandbrink R, Zhang D, Schaeffer S, Masters CL, Bauer J, Förstl H, Beyreuther K(1996) Missense mutations of the PS-1/S182 gene in German early-onset Alzheimer’s disease patients. Ann Neurol 40: 265–266

    PubMed  CAS  Google Scholar 

  • Saunders AM, Schmader K, Breitner JCS et al. (1993) Apolipoprotein E4 allele distributions in late-onset Alzheimer’s disease and in other amyloid-forming diseases. Lancet 342: 710–711

    PubMed  CAS  Google Scholar 

  • Saunders AM, Strittmatter WJ, Schmechel D et al. (1993) Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43: 1467–1472

    PubMed  CAS  Google Scholar 

  • Schägger H, Ohm TG (1995) Human diseases with defects in oxidative phosphorylation 2.FI FO ATP-synthase defects in Alzheimer disease revealed by blue native Polyacrylamide gel electrophoresis. Eur J Biochem 227: 916–921

    PubMed  Google Scholar 

  • Schellenberg GD, Bird TD, Wijsman EM et al. (1992) Genetic linkage evidence for a familial Alzheimer’s disease locus on chromosome 14. Science 258: 668–671

    PubMed  CAS  Google Scholar 

  • Schellenberg GD, Payami H, Wijsman EM et al. (1993) Chromosome 14 and late-onset familial Alzheimer’s disease (FAD) Hum Genet 53: 619–628

    CAS  Google Scholar 

  • Scott WK, Yainaoka LH, Locke PA et al. (1997) No Association or Linkage Between an Intronic Polymorphism of Presenelin-1 and Sporadic or Late-Onset Familial Alzheimer Disease. Genetic Epidemiology 14: 307–315

    PubMed  CAS  Google Scholar 

  • Sherrington R, Rogaev EI, Liang Y et al. (1995) Cloning of a gene bearing misssense mutations in earlyonset familial Alzheimer’s Disease. Nature 375: 754–760

    PubMed  CAS  Google Scholar 

  • Silverman JM, Li G, Zaccario ML, Smith CJ, Schmeidler J, Mohs RC, Davis KL (1994) Patterns of Risk in First-Degree Relatives of Patients With Alzheimer’s Disease. Arch Gen Psychiatry 51: 577–586

    PubMed  CAS  Google Scholar 

  • Silverman JM, Raiford K, Edland S, Fillenbaum G, Morris JC, Clark C, Kukall W, Heyman A (1994b) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD), VI: family history assessment: a multi-center study of first-degree relatives of Alzheimer’s disease probands and nondemented spouse controls. Neurology 44: 1253–1259

    PubMed  CAS  Google Scholar 

  • Singleton AB, Smith G, Gibson AM, Woodward R, Perry RH, Ince PG, Edwardson JA, Morris CM (1998) No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer’s disease. Hum Mol Genet 7: 937–939

    PubMed  CAS  Google Scholar 

  • Small GW, Ebeling SC, Matsuyaina SS, Heyman A, Reisner EG, Renvoize EB, Sulkava R (1991) Variable Association of HLA-A2 in Men with Early-Onset Alzheimer Disease. Neurobiology of Aging 12: 375–377

    PubMed  CAS  Google Scholar 

  • Small GW, Matsuyama SS (1986) HLA-A2 as a Possible Marker for Early-Onset Alzheimer Disease in Men. Neurobiology of Aging 7: 211–214

    PubMed  CAS  Google Scholar 

  • Small GW, Matsuyama SS, Komanduri R, Spar JE, Fairbanks L (1989) HLA Antigens in Depressed, Demented, and Nondemented Elderly. J Geriatr Psychiatry Neurol 2: 70–75

    PubMed  CAS  Google Scholar 

  • Sorbi S, Nacmias B, Forleo P, Piacentini S, Latorraca S, Amaducci L (1995) Epistatic Effect of APP717 Mutation and Apolipoprotein E Genotype in Familial Alzheimer’s Disease. Ann Neurol 38: 124–127

    PubMed  CAS  Google Scholar 

  • Sorbi S, Nacmias B, Forleo P, Piacentini S, Sherrington R, Rogaev E, St George-Hyslop P, Amaducci L (1995) Missense mutation of S182 gene in Italian families with early-onset Alzheimer’s disease. Lancet 346: 439–440

    PubMed  CAS  Google Scholar 

  • St Clair D, Rennie M, Slorach E, Norrman J, Yates C, Carothers A (1995) Apolipoprotein E e4 allele is a risk factor for familial and sporadic presenile Alzheimer’s disease in both homozygote and heterozygote carriers. J Med Genet 32: 642–644

    PubMed  CAS  Google Scholar 

  • St. George-Hyslop P, Haines J, Rogaev E et al. (1992) Genetic evidence for a novel familial Alzheimer’s disease locus on chromosome 14. Nature Genet 2: 330–334

    PubMed  CAS  Google Scholar 

  • St. George-Hyslop PHS, Tanzi RE, Polinsky RJ et al. (1987) The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science 235: 885–890

    PubMed  CAS  Google Scholar 

  • Sulkava R, Koskimies S, Wikström J, Palo J(1980) HLA Antigens in Alzheimer’s Disease. Tissue Antigens 16:191–194

    PubMed  CAS  Google Scholar 

  • Swerdlow RH, Parks JK, Cassarino DS, Maguire DJ, Maguire RS, Bennett JP, Davis RE, Parker WD (1997) Cybrids in Alzheimer’s disease: A cellular model of the disease? Neurology 49: 918–925

    PubMed  CAS  Google Scholar 

  • Tsuang D, Kukull W, Sheppard L et al. (1996) Impact of Sample Selection on APOE e4 Allele Frequency: A Comparison of Two Alzheimer’s Disease Samples. J Am Geriatr Soc 44: 704–707

    PubMed  CAS  Google Scholar 

  • Tsuda T, Lopez R, Rogaeva EA et al. (1994) Are the Associations Between Alzheimer’s Disease and Polymorphisms in the Apolipoprotein E and the Apolipoprotein CII Genes Due to Linkage Disequilibrium?Ann Neurol 36: 97–100

    PubMed  CAS  Google Scholar 

  • Tysoe C, Galinsky D, Robinson D, Brayne CE, Easton DF, Huppert FA, Dening T, Paykel ES, Rubinsztein DC (1997) Analysis of Alpha-1 Antichymotrypsin, Presenilin-1, Angiotensin-Converting Enzyme, and Methylenetetrahydrofolate Reductase Loci as Candidates for Dementia. American Journal of Medical Genetics 74: 207–212

    PubMed  CAS  Google Scholar 

  • Tysoe C, Galinsky D, Robinson D et al. (1998) ApoE and Apo CI Loci Are Associated with Dementia in Younger But Not Older Late-Onset Cases. Dement Geriatr Cogn Disord 9: 191–198

    PubMed  CAS  Google Scholar 

  • Van Broeckhoven C et al (1994) APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer’s disease. Neurosci.

    Google Scholar 

  • Lett Van Duijn CM, Clayton D, Chandra V et al. (1991) Familial Aggregation of Alzheimer’s Disease and Related Disorders: A Collaborative Re-Analysis of Case-Control Studies. International Journal of Epidemiology 20 (Suppl.2) S13–S20

    PubMed  Google Scholar 

  • Wasco W, Pettingeil WP, Jondro PD et al. (1995) Familial Alzheimer’s chromosome 14 mutations. Nature Medicine 1: 848

    PubMed  CAS  Google Scholar 

  • Whalley LJ, Urbaniak SJ, Darg C, Peutherer JF, Christie JE (1980) Histocompatibility antigens and antibodies to viral and other antigens in Alzheimer pre-senile dementia. Acta Psychiat Scand 61: 1–7

    PubMed  CAS  Google Scholar 

  • Wragg M, Hutton M, Talbot C (1996) Genetic association between intronic polymorphism in presenelin-1 gene and late-onset Alzheimer’s disease. Lancet 347: 509–512

    PubMed  CAS  Google Scholar 

  • Xia Y, Rohan de Silva HA, Rosi BL et al. (1996) Genetic Studies in Alzheimer’s Disease with an NACP/a-Synuclein Polymorphism. Ann Neurol 40: 207–215

    PubMed  CAS  Google Scholar 

  • Yoshiiwa A, Kamino K, Yamamoto H et al. (1997) al-Antichymotrypsin as a Risk Modifier for Late-Onset Alzheimer’s Disease in Japanese Apolipoprotein E e4 Allele Carriers. Ann Neurol 42: 115–117

    PubMed  CAS  Google Scholar 

  • Yu CE, Payami H, Olson JM et al. (1994) The Apolipoprotein E/CI/CII Gene Cluster and Late-Onset Alzheimer Disease. Am J Hum Genet 54: 631–642

    PubMed  CAS  Google Scholar 

  • Zsurka G, Kaiman J, Juhäsz A, Császár A, Raskò I, Janka Z, Venetianer P(1998) No Mitochondrial Haplotype Was Found to Increase Risk for Alzeimer’s Disease. Society of Biological Psychiatry 44: 371–373

    CAS  Google Scholar 

  • Zubenko GS, Huff FJ, Beyer J, Auerbach J, Teply I (1988) Familial Risk of Dementia Associated With a Biologie Subtype of Alzheimer’s Disease. Archives of General Psychiatry 45: 889–893

    PubMed  CAS  Google Scholar 

  • Zubenko GS, Hughes HB, Stiffler JS, Hurtt MR, Kaplan BB (1998) A Genome Survey for Novel Alzheimer Disease Risk Loci: Results at 10-cM Resolution. Genomics 50: 121–128

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Heun, R., Papassotiropoulos, A. (1999). Genetik der Alzheimer Demenz. In: Förstl, H., Bickel, H., Kurz, A. (eds) Alzheimer Demenz. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60228-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60228-3_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64313-2

  • Online ISBN: 978-3-642-60228-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics